Skip to main content
. Author manuscript; available in PMC: 2011 Jun 21.
Published in final edited form as: Org Biomol Chem. 2010 May 6;8(12):2719–2727. doi: 10.1039/c001036g

Fig. 1.

Fig. 1

(A) Schematic representation of the eukaryotic 20S proteasome and previously described β1 and β5 specific proteasome inhibitors. The proteolytically active β subunits are marked in red. (B) Recognition elements I and II and warheads a–c resulting in 6 hybrid structures, Ia–c and IIa–c.